GRCE

Grace Therapeutics
GRCE

17 hedge funds and large institutions have $9.17M invested in Grace Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.71M
2
+$2.52M
3
+$928K
4
PWM
Palumbo Wealth Management
New York
+$145K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$95.8K

Top Sellers

1
-$1.36M
2
-$2.5K
3
-$116
4
Morgan Stanley
Morgan Stanley
New York
-$107
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$85
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.02M
2
$2.69M
3
$1.13M
4
$783K
5
$666K
6
$582K
7
$105K
8
$96.2K
9
$87.6K
10
$7.82K
11
$6.12K
12
$4.21K
13
$1K
14
$237
15
$230
16
$34
17
$2
18
–